Model Based Network Meta-Analysis for Pharmacometrics and Drug-Development: A 3 year Research Collaboration between Pfizer and the University of Bristol

被引：0
|
作者：
Mawdsley, David [1 ]
Bennetts, Meg [2 ]
Dias, Sofia [1 ]
Boucher, Martin [2 ]
Ades, Tony [1 ]
Welton, Nicky J. [1 ]
机构：
[1] Univ Bristol, Sch Social & Community Med, Bristol BS8 1TH, Avon, England
[2] Pfizer Ltd, Global Clin Pharmacol, Pharmacometr, New York, NY USA
来源：
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS | 2015年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
W-37
引用
收藏
页码：S91 / S92
页数：2
相关论文
共 18 条
  • [1] Applications of Model-Based Meta-Analysis in Drug Development
    Phyllis Chan
    Kirill Peskov
    Xuyang Song
    [J]. Pharmaceutical Research, 2022, 39 : 1761 - 1777
  • [2] Applications of Model-Based Meta-Analysis in Drug Development
    Chan, Phyllis
    Peskov, Kirill
    Song, Xuyang
    [J]. PHARMACEUTICAL RESEARCH, 2022, 39 (08) : 1761 - 1777
  • [3] ESTABLISHMENT OF AN INNOVATIVE COLLABORATIVE BETWEEN THE DRUG SAFETY AND EFFECTIVENESS NETWORK IN CANADA AND ISPOR FOR APPLICATION AND DEVELOPMENT OF NETWORK META-ANALYSIS
    Lee, K.
    Shukla, V
    Coyle, D.
    Wells, G.
    [J]. VALUE IN HEALTH, 2012, 15 (04) : A7 - A7
  • [4] Model-Based Meta-Analysis to Improve Drug Development Decisions for Weight Loss Compounds
    Zierhut, Matthew L.
    Samtani, Mahesh N.
    Pinheiro, Jose
    Wong, Peggy
    [J]. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2018, 45 : S77 - S78
  • [5] Longitudinal Model-Based Meta-Analysis in Rheumatoid Arthritis: An Application Toward Model-Based Drug Development
    Demin, I.
    Hamren, B.
    Luttringer, O.
    Pillai, G.
    Jung, T.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 92 (03) : 352 - 359
  • [6] Model-Based Meta-Analysis for Comparative Efficacy and Safety: Application in Drug Development and Beyond
    Mandema, J. W.
    Gibbs, M.
    Boyd, R. A.
    Wada, D. R.
    Pfister, M.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 90 (06) : 766 - 769
  • [7] Model-Based Meta-Analysis: An Important Tool for Making Quantitative Decisions During Drug Development
    Mould, D. R.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 92 (03) : 283 - 286
  • [8] Model-Based Meta-Analysis: Optimizing Research, Development, and Utilization of Therapeutics Using the Totality of Evidence
    Upreti, Vijay V.
    Venkatakrishnan, Karthik
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 106 (05) : 981 - 992
  • [9] Model-Based Meta-Analysis for Multiple Myeloma: A Quantitative Drug-Independent Framework for Efficient Decisions in Oncology Drug Development
    Teng, Zhaoyang
    Gupta, Neeraj
    Hua, Zhaowei
    Liu, Guohui
    Samnotra, Vivek
    Venkatakrishnan, Karthik
    Labotka, Richard
    [J]. CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2018, 11 (02): : 218 - 225
  • [10] Performance evaluation of China's innovation during the industry-university-research collaboration process—an analysis basis on the dynamic network slacks-based measurement model
    Bai, Xue-Jie
    Li, Zhen-Yang
    Zeng, Jin
    [J]. Technology in Society, 2020, 62
12